104800-03-5

Basic information

• Product Name: Acetamide, N-[4-(3-chloropropoxy)phenyl]-
• Synonyms: N-[4-(3-chloropropoxy)phenyl]acetamide;Acetamide, N-[4-(3-chloropropoxy)phenyl]-
• CAS NO: 104800-03-5
• Molecular Formula: C₁₁H₁₄ClNO₂
• Molecular Weight: 227.69
• Mol File: 104800-03-5.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Acetamide, N-[4-(3-chloropropoxy)phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Acetamide, N-[4-(3-chloropropoxy)phenyl]-(104800-03-5)
• EPA Substance Registry System: Acetamide, N-[4-(3-chloropropoxy)phenyl]-(104800-03-5)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 104800-03-5(Hazardous Substances Data)

Upstream product

• 103-90-2 4-acetaminophenol 
• 109-70-6 1.3-chlorobromopropane 
• 928256-57-9 4-(3-chloropropoxy)aniline 
• 108-24-7 acetic anhydride 
• 107167-08-8 1-bromo-1-chloropropane 

Downstream Products

• 111627-14-6 N-[4-[3-[4-[bis(4-fluorophenyl)methyl]-1-piperidinyl]propoxy]phenyl]acetamide 
• 111626-60-9 N-[4-(3-{4-[Bis-(4-fluoro-phenyl)-hydroxy-methyl]-piperidin-1-yl}-propoxy)-phenyl]-acetamide; hydrochloride 
• 57925-57-2 N-[4-(3-chloropropoxy)-2-nitrophenyl]acetamide 
• 85868-52-6 1-(4-acetamidophenoxy)-3-1-(N⁴-phenylpiperazinyl)>propane 
• 111626-57-4 N-[4-[3-[4-[Bis(4-fluorophenyl)methyl]-1-piperidinyl]propoxy]phenyl]acetamide hydrobromide 

Relevant articles and documents

Design and synthesis of newer potential 4-(N-acetylamino)phenol derived piperazine derivatives as potential cognition enhancers

A series of novel hybrids has been designed, synthesized and evaluated for cognition enhancing activities through the inhibition of acetylcholinesterase (AChE) and by passive avoidance mouse model. All the compounds showed excellent AChE inhibition activi

Synthesis of 4-(1-oxo-isoindoline)-, 4-(5,6-dimethoxy-1-oxo-isoindoline) and 4-acetamido-substituted phenoxy-3-amino-propane derivatives and their β1-, β2- adrenergic receptor binding studies

In continuation to our previous study of 4-(1-oxo-isoindoline)- and 4-(5,6-dimethoxy-l-oxo-isoindoline)-substituted phenoxypropanolamines as potential cardioselective β-adrenergic blocking agents, the synthesis of 4-(1-oxo-isoindoline) and 4-(5,6-dimethox

Arylalkylheterocyclic amines,N-substituted by aryloxyalkyl group in a method for allergy treatment

A method of inhibiting Type 1 allergic responses in a living animal body with substituted heterocyclic amines is disclosed wherein the active agents are expressed generally by the formula which includes certain known and certain known compounds: STR1 wherein P is zero, one or two; m is one to six inclusive; A is selected from hydrogen, hydroxy or cyano; d is zero or one; Q is --CH--, CH2 -- or STR2 n is zero or one and when Q is --CH-- and n is one, a double bond is formed with one of the adjacent carbons but not both at the same time, and when n and d are zero at the same time, a double bond is formed between the α carbon and a carbon of the central heterocyclic amine ring; Ar, D and R are selected from phenyl, substituted phenyl, pyridinyl, thienyl, furanyl or naphthyl and in addition, R may have the values benzyl, substituted benzyl, cycloalkyl or loweralkyl and D may additionally have the values: 2H-1-benzopyran-2-one,4-oxo-4H-1-benzopyran-2-carboxylic acid loweralkyl ester, 2,3-dihydro-4H-1-benzopyran-4-one, 1,4-benzodioxanloweralkyl-2-yl or 1,1'-biphenyl-4-yl and the pharmaceutically acceptable salts thereof.